Selection of drugs in pursuit of rate control strategy.
Atrial fibrillation is the most common sustained arrhythmia. Based on multiple large randomized trials, rate control therapy has been shown to be safe and effective and is gaining greater acceptance as a frontline alternative to drugs to maintain sinus rhythm. Adequate rate control can be achieved by atrioventricular nodal blocking agents both in the acute and chronic settings. In refractory patients, other methods such as atrioventricular node ablation can be used to control rate.
Samii
Soraya M
SM
Division of Cardiology, Pennsylvania State Cardiovascular Center, Penn State University College of Medicine, The Milton S. Hershey Medical Center, Hershey, PA 17033, USA.
Hynes
B John
BJ
Khan
Mazhar
M
Wolbrette
Deborah L
DL
Luck
Jerry C
JC
Naccarelli
Gerald V
GV
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000503:physiopathology / Q000628:therapy; D017147:Defibrillators, Implantable; D006329:Heart Conduction System / Q000187:drug effects / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans
D000889:Anti-Arrhythmia Agents